Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Y Cahn

Showing results (121-130 of 178) with videos related to

Pageof 18
Sort By:
Bone Marrow Transplantation|January 7, 1998
Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia in first remission: long-term results for 42 patients conditioned with an intensified regimen (TBI, high-dose Ara-C and melphalan)E Deconinck, J Y Cahn, N Milpied, et al.
Leukemia|July 6, 2007
A retrospective comparison of autologous and unrelated donor hematopoietic cell transplantation in myelodysplastic syndrome and secondary acute myeloid leukemia: a report on behalf of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)H K Al-Ali, R Brand, A van Biezen, et al.
Hematology and Cell Therapy|October 1, 1996
[Utilization of herpes simplex virus-1 thymidine kinase gene in stem cell transplantation therapy]P Tiberghien, J Y Cahn, C Ferrand, et al.
Blood|May 29, 2000
Effect of nucleated marrow cell dose on relapse and survival in identical twin bone marrow transplants for leukemiaA J Barrett, O Ringdén, M J Zhang, et al.
Blood|June 11, 1999
Final height of patients who underwent bone marrow transplantation for hematological disorders during childhood: a study by the Working Party for Late Effects-EBMTA Cohen, A Rovelli, B Bakker, et al.
European Journal of Haematology|May 23, 2024
Rapid response system for critically ill patients with haematological malignancies: A pre- and post-intervention studyN Mauz, M Bouisse, J Y Cahn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trialC Guglielmi, F Gomez, T Philip, et al.
Human Gene Therapy|March 20, 1997
Use of donor T-lymphocytes expressing herpes-simplex thymidine kinase in allogeneic bone marrow transplantation: a phase I-II studyP Tiberghien, J Y Cahn, A Brion, et al.
Blood|September 10, 1998
Treatment-related deaths and second cancer risk after autologous stem-cell transplantation for Hodgkin's diseaseM André, M Henry-Amar, D Blaise, et al.
Leukemia|September 26, 1997
Age-adapted induction treatment of acute lymphoblastic leukemia in the elderly and assessment of maintenance with interferon combined with chemotherapy. A multicentric prospective study in forty patients. French Group for Treatment of Adult Acute Lymphoblastic LeukemiaA Delannoy, C Sebban, P Cony-Makhoul, et al.
Pageof 18

Showing results (121-130 of 178) with videos related to

Sort By:
Pageof 18
Bone Marrow Transplantation|January 7, 1998
Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia in first remission: long-term results for 42 patients conditioned with an intensified regimen (TBI, high-dose Ara-C and melphalan)E Deconinck, J Y Cahn, N Milpied, et al.
Leukemia|July 6, 2007
A retrospective comparison of autologous and unrelated donor hematopoietic cell transplantation in myelodysplastic syndrome and secondary acute myeloid leukemia: a report on behalf of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)H K Al-Ali, R Brand, A van Biezen, et al.
Hematology and Cell Therapy|October 1, 1996
[Utilization of herpes simplex virus-1 thymidine kinase gene in stem cell transplantation therapy]P Tiberghien, J Y Cahn, C Ferrand, et al.
Blood|May 29, 2000
Effect of nucleated marrow cell dose on relapse and survival in identical twin bone marrow transplants for leukemiaA J Barrett, O Ringdén, M J Zhang, et al.
Blood|June 11, 1999
Final height of patients who underwent bone marrow transplantation for hematological disorders during childhood: a study by the Working Party for Late Effects-EBMTA Cohen, A Rovelli, B Bakker, et al.
European Journal of Haematology|May 23, 2024
Rapid response system for critically ill patients with haematological malignancies: A pre- and post-intervention studyN Mauz, M Bouisse, J Y Cahn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trialC Guglielmi, F Gomez, T Philip, et al.
Human Gene Therapy|March 20, 1997
Use of donor T-lymphocytes expressing herpes-simplex thymidine kinase in allogeneic bone marrow transplantation: a phase I-II studyP Tiberghien, J Y Cahn, A Brion, et al.
Blood|September 10, 1998
Treatment-related deaths and second cancer risk after autologous stem-cell transplantation for Hodgkin's diseaseM André, M Henry-Amar, D Blaise, et al.
Leukemia|September 26, 1997
Age-adapted induction treatment of acute lymphoblastic leukemia in the elderly and assessment of maintenance with interferon combined with chemotherapy. A multicentric prospective study in forty patients. French Group for Treatment of Adult Acute Lymphoblastic LeukemiaA Delannoy, C Sebban, P Cony-Makhoul, et al.
Pageof 18